AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| 1 |
Broadcom
AVGO
|
$683M |
| 2 |
Cboe Global Markets
CBOE
|
$403M |
| 3 |
Apple
AAPL
|
$358M |
| 4 |
TSMC
TSM
|
$352M |
| 5 |
Eli Lilly
LLY
|
$328M |
Top Sells
| 1 |
Microsoft
MSFT
|
$1.29B |
| 2 |
Alphabet (Google) Class C
GOOG
|
$636M |
| 3 |
West Pharmaceutical
WST
|
$562M |
| 4 |
Idexx Laboratories
IDXX
|
$444M |
| 5 |
Visa
V
|
$387M |
Sector Composition
| 1 | Technology | 26.49% |
| 2 | Healthcare | 13.1% |
| 3 | Financials | 12.21% |
| 4 | Consumer Discretionary | 11.26% |
| 5 | Communication Services | 9.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3151
Vera Bradley
VRA
$60.9M
| $40.9K | ﹤0.01% |
18,190
-2,900
| -14% | -$6.53K |
|
3152
Compass Therapeutics
CMPX
$466M
| $40.7K | ﹤0.01% |
21,440
| – | – |
|
|
NOVA
3153
DELISTED
Sunnova Energy
NOVA
| $40.4K | ﹤0.01% |
108,550
-19,778
| -15% | -$7.36K |
|
3154
scPharmaceuticals
SCPH
$300M
| $40K | ﹤0.01% |
15,210
| – | – |
|
3155
Waldencast
WALD
$196M
| $37.8K | ﹤0.01% |
12,610
+400
| +3% | +$1.2K |
|
3156
BigBear.ai
BBAI
$1.83B
| $37.5K | ﹤0.01% |
13,100
-44,490
| -77% | -$127K |
|
3157
Zura Bio
ZURA
$135M
| $37.2K | ﹤0.01% |
28,840
| – | – |
|
3158
Biote Corp
BTMD
$107M
| $36.5K | ﹤0.01% |
10,970
| – | – |
|
3159
Kaltura
KLTR
$229M
| $35.7K | ﹤0.01% |
18,990
| – | – |
|
3160
Black Diamond Therapeutics
BDTX
$163M
| $33.5K | ﹤0.01% |
21,640
| – | – |
|
3161
Nektar Therapeutics
NKTR
$684M
| $33.5K | ﹤0.01% |
3,280
| – | – |
|
3162
Cardiff Oncology
CRDF
$142M
| $32.6K | ﹤0.01% |
10,380
| – | – |
|
|
INZY
3163
DELISTED
Inozyme Pharma
INZY
| $31.8K | ﹤0.01% |
34,990
| – | – |
|
3164
HilleVax
HLVX
$105M
| $31.7K | ﹤0.01% |
21,850
| – | – |
|
3165
ADC Therapeutics
ADCT
$382M
| $31K | ﹤0.01% |
22,020
| – | – |
|
3166
Generation Bio
GBIO
$38.9M
| $29.2K | ﹤0.01% |
7,216
| – | – |
|
3167
Gerdau
GGB
$6.15B
| $29K | ﹤0.01% |
+10,225
| New | +$29K |
|
3168
Ispire Technology
ISPR
$177M
| $29K | ﹤0.01% |
10,610
| – | – |
|
3169
Tenaya Therapeutics
TNYA
$202M
| $28.3K | ﹤0.01% |
49,570
| – | – |
|
|
BITF
3170
Bitfarms
BITF
$691M
| $27.4K | ﹤0.01% |
34,800
| – | – |
|
3171
Rekor Systems
REKR
$135M
| $27.1K | ﹤0.01% |
30,600
| – | – |
|
3172
X4 Pharmaceuticals
XFOR
$81.7M
| $25.9K | ﹤0.01% |
3,652
| – | – |
|
|
QIPT
3173
Quipt Home Medical
QIPT
$113M
| $25.7K | ﹤0.01% |
11,050
| – | – |
|
3174
PepGen
PEPG
$42M
| $24.8K | ﹤0.01% |
17,650
| – | – |
|
|
GCTS
3175
GCT Semiconductor Holding
GCTS
$70.9M
| $24.6K | ﹤0.01% |
14,980
| – | – |
|